Medicine & Life Sciences
Glucose
100%
Peptides
76%
Glucagon-Like Peptide 1
64%
Insulin
58%
Hypoglycemic Agents
58%
gastric inhibitory polypeptide receptor
50%
Dipeptidyl Peptidase 4
46%
glycosylated insulin
44%
Gastric Inhibitory Polypeptide
40%
Insulin Secretion
40%
glucagon-like peptide 1 (7-36)amide
35%
Insulin-Secreting Cells
34%
Glucagon
29%
Pro(3)-glucose-dependent insulinotropic polypeptide
29%
Type 2 Diabetes Mellitus
25%
Glucagon Receptors
25%
Protein Hydrolysates
24%
apelin-13 peptide
23%
cholecystokinin 8
20%
Incretins
19%
Obesity
19%
Amides
19%
glucagon-like peptide 1 (7-37)
17%
exendin (9-39)
15%
Nateglinide
15%
Sorbitol
14%
Obese Mice
14%
Insulin Resistance
14%
Radioimmunoassay
13%
Hormones
13%
glucagon-like peptide-1 (9-36)-amide
12%
Fats
12%
neuromedin U
11%
Islets of Langerhans
11%
In Vitro Techniques
11%
Glucagon-Like Peptide-1 Receptor
11%
Metformin
11%
Apelin
11%
Homeostasis
10%
Eating
10%
pro-glucose-dependent insulinotropic polypeptide
10%
Cholecystokinin
9%
Anura
9%
Body Weight
9%
Cyclic AMP
9%
Rana ridibunda
9%
Abdominal Muscles
8%
Enzymes
8%
Neurokinin B
8%
neuromedin U 25
7%
Chemistry
Insulinotropic
99%
Insulin Derivative
65%
Polypeptide
41%
Glucose
38%
Antidiabetic Agent
27%
Peptide
27%
Glucagon
20%
Glycation
15%
Hormone
15%
Amide
14%
Glucagon Receptor Antagonist
14%
Neuromedin U
13%
Ablation
13%
Plasma
13%
Apelin-13
13%
Metabolic
12%
Glycemic
12%
Bioactivity
11%
Hyperglycemic
10%
Neurokinin B
9%
Agonist
9%
Agent Interacting With Transmitter, Hormone or Drug Receptor
8%
Resistance
7%
Cholecystokinin-8
7%
Weight
7%
Pharmacological Metabolism
7%
Food
6%
Intraperitoneal
6%
Substitution Reaction
6%
Insulin (Human)
6%
Antagonist
6%
Fatty Acid
5%
Fat
5%
Twice Daily
5%